The purpose of this study is to test if sonrotoclax in combination with zanubrutinib is safe and if it works better in adult participants with R/R MCL comparing it with when zanubrutinib is given in combination with sonrotoclax-matched placebo.
Learn more about the BGB-11417-302 trial or call the Cancer Research Office at Reading Hospital at 484-628-8193.
